Healthcare Professionals
Amplia MRI Quad CRT-D
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
MRI Access
CRT Patients are not Receiving MRIs
Data from 2012 were used to project MRI utilization in the CRT patient cohort over 4 years: whereas the actual MRI utilization rate over 4 years was measured in the non-CRT cohort.
*
CRT patients likely to receive an MRI is between 1.45% and 2.40%.
CRT Patients are not Receiving MRIs and are Likely to Need them
With Amplia MRI™, patients have access to 1.5T and 3T full-body MRI scanning
BUILT TO BE SCANNED
Our SureScan™ devices and leads work in any combination to provide simplified scanning conditions
We engineered our devices with enhancements to ensure patient safety against:
- force, torque and heating
- unintended cardiac stimulation
- device interactions in the MRI
References
1
Medtronic data on file 2016: Data from MarketScan® 2012 Commercial and Medicare Database, Truven Health Analytics.
2
Gold MR, Kanal E, Schwitter J, et al. Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use. Heart Rhythm. March 2015;12(3):631-638.
3
Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. January 2011;8(1):65-73.
4
Ramza B, et al. Are There Cumulative Effects of Multiple MRI on MR-conditional Pacemakers? Presented at HRS, May 2014.
5
Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm. May 2013;10(5):685-691.
6
Evaluation of Approved Pacing Lead (Model 5076) for Use in MRI Environment, clinicaltrials.gov, NCT01755143.
7
Confirmatory Clinical Trial of the Evera MRI System for Conditionally-Safe MRI Access, clinicaltrials.gov, NCT02117414.
8
Poor, Corinne. MRI™ SureScan™ Units Sold from FY09 – FY15. June 2015. Medtronic Data on File.